Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates

Messenger RNA (mRNA) vaccine technology has shown its power in preventing the ongoing COVID-19 pandemic. Two mRNA vaccines targeting the full-length S protein of SARS-CoV-2 have been authorized for emergency use. Recently, we have developed a lipid nanoparticle-encapsulated mRNA (mRNA-LNP) encoding...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hui, Wang, Tie-Cheng, Li, Xiao-Feng, Zhang, Na-Na, Li, Liang, Zhou, Chao, Deng, Yong-Qiang, Cao, Tian-Shu, Yang, Guan, Li, Rui-Ting, Huang, Yi-Jiao, Li, Yuan-Guo, Zhang, Yi-Ming, Li, Fang-Xu, Zhou, Yu-Ren, Jiang, Yu-Hang, Lu, Xi-Shan, Sun, Shi-Hui, Cheng, Meng-Li, Gu, Kai-Ping, Zhang, Mei, Ma, Qing-Qing, Yang, Xiao, Ying, Bo, Gao, Yu-Wei, Qin, Cheng-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703211/
https://www.ncbi.nlm.nih.gov/pubmed/34952914
http://dx.doi.org/10.1038/s41392-021-00861-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703211/
https://www.ncbi.nlm.nih.gov/pubmed/34952914
http://dx.doi.org/10.1038/s41392-021-00861-4

Ejemplares similares